Verizon Extends Healthcare Focus to Pharmaceutical Sector

Verizon is extending its healthcare focus to include the pharmaceutical and life sciences industries, the company announced at the Drug Information Association show (Booth #438) in San Diego, Calif. Verizon, who has been helping to transform the delivery of healthcare in the U.S. through a growing portfolio of IT solutions, unveiled two new industry-specific solutions designed to help companies keep up with increasing regulatory requirements for this sector.
"Companies within the sector are struggling today to meet growing regulatory requirements," said Rich Black, vice president of Verizon’s healthcare practice. "We have found that our IT infrastructure which leverages our cloud, security and technical expertise can enable them to address this burden. We recently met with several large pharmaceutical companies and they were energized to learn that Verizon’s infrastructure services can be used to address what is clearly a pain point for them."
Available immediately in the U.S. and Europe, Verizon is launching a portfolio of GxP (Good x Practices) Services for managing sensitive clinical and drug manufacturing data in the Verizon cloud or from select data centers. The company also entered into a partnership agreement with rfXcel whereby Verizon will provide its complementary cloud and data center service options to clients. rfXcel provides a serialization solution that helps companies track and trace pharmaceuticals from manufacturing to distribution.